INTERLEtrKIN-I levels are elevated in inflammatory bowel disease. In this study the mechanism by which interleukin-l affects electrolyte transport in the rabbit distal colon, was investigated. Interleukin-l caused a delayed increase in short-circuit current (Isc) which was attributed to protein synthesis since the effect was inhibited by cycloheximide. The interleukin-l induced increase in Isc was not affected by amiloride treatment but was completely inhibited by bumetanide or in chloridefree buffer and by indomethacin. Prostaglandin E levels increased in tissue treated with interleukin-l, but this increase was reversed by cycloheximide. These data suggest that interleukin-l causes its effect via a yet to be identified second messenger, by increasing chloride secretion through a prostaglandin E mediated mechanism.
Introduction
IL-1 is a cytokine of around 17 kDa which is responsible for mediating a variety of processes in host defence, inflammation, and response to injury. It is produced by diverse cell types following infection or injury. On the basis of several overlapping activities and similar patterns of production, IL-1 may be grouped with tumour necrosis factor-(TNF0t, and IL-6 as factors mediating common effects. 2, 3 It is produced by a variety of cells such as fibroblasts and T and B lymphocytes and consists of two distinct but related molecules, IL-10t and IL-I[ which are encoded by separate genes; in most human tissues IL-1[3 mRNA predominates over IL-10t mRNA. Both forms appear to function by binding to the same membrane-associated receptor. IL-1 appears to be a primary molecule in inflammatory reactions through its induction of other inflammatory metabolites, e.g. it induces production of prostaglandin E (POE2) and phospholipase a (PEA2).
In the intestine, increased IL-1 production has been reported in the mucosa of patients with inflammatory bowel disease and in intestinal tissue of animal models of colitis TM suggesting that IL-1 may be involved in the pathophysiology of inflammatory bowel disease. IL-1 has been shown to stimulate el:
and HCO3-secretion in the chicken intestine 12 and inhibit Na and C1-absorption in rabbit ileum, 1 however, the role and mechanism of action of IL-1 in affecting secretory function in the normal colon has not been fully elucidated.
More than one second messenger seems to be involved in mediating the effects of IL-1. Some of these mediators include nitric oxide (NO), cAMP and phospholipases C and A2 .14 '15 Atropine alone had no effect on Isc and had no effect on IL-l-induced increases in Isc. TTX (Fig. 3) .
Bumetanide (10 laM), an inhibitor of the Na+/K+/2Cl transporter present on the basolateral membranes of the crypt cells, had no effect on Isc alone, also caused complete inhibition of the effect of IL-lJ3 on Isc ( by increasing Cl-secretion significantly with no effect on Na ion movement through the apical Na channel. In pancreatic islet cells, IL-1 was shown to activate the Na//H exchanger and cause a rapid increase in cytosolic Na concentration. 21 Since there is no evidence for the presence of the Na//H exchanger in rabbit distal colon, the only possible explanation for the increased Isc is an increase in C1-secretion.
Most of the effects of IL-113 on Isc and PGE2 production were found to be through protein synthesis. Induction of protein synthesis in response to IL-1 treatment has been reported in a variety of cells. [22] [23] [24] [25] In these studies, alterations in phospholipid metabolism were observed. These were primarily due to increased PLA2 activity which occurred in response to IL-1 and which was attributed to induced synthesis of a phospholipase A activating protein. 26 In human umbilical vein endothelial cells, IL-1 has recently been shown to induce cyclooxygenase-2 expression through a post-transcriptional regulation. 27 In insulinsecreting cells IL-1 modulates the expression of specific proteins, not yet identified, but might represent heat shock protein, superoxide dismutase, or other proteins involved in the functional response of the islet to oxidative stress and free radical formation. 28 Although the cell surface receptor for IL-1 has been cloned, 29 it is still largely unknown how it transmits information to the inside of the cell after IL-1 binding. The intracellular signals induced by IL-1 appear to be complex because IL-1 seems to use multiple signal transduction pathways. 14, 15 In the beta cell, for example, nitric oxide (NO) has been implicated as the effector molecule responsible for some of the effects of IL-1 on cell function. NG-monomethyl-L-arginine (NM.MA) and NAME, both of which are competitive inhibitors of nitric oxide synthase, prevent the inhibitory effects of IL-I[ on glucose-stimulated insulin secretion by isolated islets. 3 In our study, however, using a NOS inhibitor, we found no evidence for NO being a mediator for IL-1 action.
More than one second messenger seems to be involved in mediating the effects of IL 37 In conclusion, this study demonstrates that IL-1 has profound effects on the secretory function of the normal distal colon. Since IL-1 is significantly increased in inflammatory bowel disease, an understandin'g of its mechanism of action on electrolyte transport in the colon will lead to greater insights into the pathophysiology of inflammatory bowel disease and possibly new therapeutic modalities.
